Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01933906
What this trial is testing

Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Arbeitsgemeinschaft medikamentoese Tumortherapie 12
Testing effectiveness (Phase 2)Study completedNCT00000687
What this trial is testing

Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT01854528
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 148
Not applicableNot Yet RecruitingNCT07537387
What this trial is testing

A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha

Who this might be right for
Chronic Hepatitis b
xieqing 10,000
Large-scale testing (Phase 3)Study completedNCT01412333
What this trial is testing

Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Hoffmann-La Roche 835
Testing effectiveness (Phase 2)Study completedNCT00059826
What this trial is testing

Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 89
Testing effectiveness (Phase 2)Study completedNCT00002506
What this trial is testing

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Who this might be right for
Cervical CancerEsophageal CancerHead and Neck Cancer+3 more
Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)Study completedNCT01432704
What this trial is testing

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of Turku 70
Testing effectiveness (Phase 2)Ended earlyNCT00057447
What this trial is testing

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma
InterMune 24
Large-scale testing (Phase 3)UnknownNCT00297570
What this trial is testing

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Who this might be right for
Leukemia, Myeloid, Philadelphia-Positive
Sheba Medical Center 90
Large-scale testing (Phase 3)Study completedNCT00287079
What this trial is testing

A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated Syndrome
Merck KGaA, Darmstadt, Germany 35
Early research (Phase 1)Study completedNCT00482989
What this trial is testing

Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus
MedImmune LLC 183
Post-approval studies (Phase 4)Study completedNCT00241618
What this trial is testing

Timing and Duration of Acute Hepatitis C Treatment

Who this might be right for
Hepatitis C
Ain Shams University 180
Not applicableStudy completedNCT05478018
What this trial is testing

Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus ErythematosusInterferon Deficiency
Rigshospitalet, Denmark 55
Not applicableStudy completedNCT04539678
What this trial is testing

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

Who this might be right for
Thrombotic PatientsDiagnosis of Myeloproliferative NeoplasiaImpact of Treatment With Cytoreducing Agent
Nantes University Hospital 253
Testing effectiveness (Phase 2)WithdrawnNCT00895882
What this trial is testing

Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Study completedNCT00938860
What this trial is testing

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Who this might be right for
Hepatitis CLiver Transplantation
Novartis Pharmaceuticals 92
Large-scale testing (Phase 3)Study completedNCT01389323
What this trial is testing

BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 448
Testing effectiveness (Phase 2)UnknownNCT01024894
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy

Who this might be right for
Hepatitis C
Cytheris SA 15
Post-approval studies (Phase 4)Active Not RecruitingNCT04035837
What this trial is testing

The Clinical Cure Project of Chronic Hepatitis B in China

Who this might be right for
Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University 30,000
Next Page